Bausch Health Companies (BHC) Depreciation & Amortization (CF) (2011 - 2026)

Bausch Health Companies has reported Depreciation & Amortization (CF) for 16 years, with the latest figure at $281.0 million in Q2 2026.

• Quarterly Depreciation & Amortization (CF) fell 8.47% year-over-year to $281.0 million in Q2 2026, while the trailing twelve-month figure through Jun 2026 was $1.2 billion (down 5.56% YoY) and the FY2025 annual result came in at $1.2 billion, down 4.66% from the prior year.
• Depreciation & Amortization (CF) declined to $281.0 million in Q2 2026 per BHC's latest filing, from $295.0 million in the prior quarter.
• Over five years, Depreciation & Amortization (CF) peaked at $360.0 million in Q4 2022 and troughed at $281.0 million in Q2 2026.
• A 5-year average of $317.2 million and a median of $316.5 million in 2023 frame the typical range for Depreciation & Amortization (CF).
• The sharpest annual moves came in 2022 and 2024: Depreciation & Amortization (CF) dropped 14.11% in 2022, then grew 6.98% in 2024.
• Over 5 years, Depreciation & Amortization (CF) stood at $360.0 million in 2022, then declined by 8.61% to $329.0 million in 2023, then fell by 6.69% to $307.0 million in 2024, then declined by 5.54% to $290.0 million in 2025, then dropped by 3.1% to $281.0 million in 2026.
• According to Business Quant data, Depreciation & Amortization (CF) over the past three periods registered $281.0 million, $295.0 million, and $290.0 million for Q2 2026, Q1 2026, and Q4 2025 respectively.